| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 10/17/2002 | CA2443277A1 Interferon gamma polypeptide variants |
| 10/17/2002 | CA2443040A1 Solid pharmaceutical composition comprising 4 -cyano-trifluoro-3-(4-fluorophenyl-sulphonyl) -2-hydroxy-2-methylpropiono- m toluidide and pvp |
| 10/17/2002 | CA2442382A1 Methods for using annexin for detecting cell death in vivo and treating associated conditions |
| 10/17/2002 | CA2442315A1 Glycosaminoglycan/collagen complexes and use thereof |
| 10/17/2002 | CA2442092A1 Oligonucleotide mediated inhibition of hepatitis b virus and hepatitis c virus replication |
| 10/17/2002 | CA2441442A1 Conjugate of hydroxyalkyl starch and an active agent |
| 10/17/2002 | CA2439111A1 Mucosal boosting following parenteral priming |
| 10/16/2002 | EP1249502A2 Beads, preparing method for the same, flow cytometer and program |
| 10/16/2002 | EP1249496A2 Methods for producing and transforming cassava protoplasts |
| 10/16/2002 | EP1249490A2 In vitro activation of cytotoxic T cells |
| 10/16/2002 | EP1249247A2 Pharmaceutical preparation for the treatment of gynecological diseases |
| 10/16/2002 | EP1249239A1 Antipruritic agents for external use |
| 10/16/2002 | EP1249238A2 Topical pharmaceutical composition comprising betanechol |
| 10/16/2002 | EP1249234A1 Method of preventing retinopathy of prematurity in a neonate |
| 10/16/2002 | EP1249232A1 Controlled release nanoparticles for percutaneous use and composition containing the same |
| 10/16/2002 | EP1248838A1 Polyampholytes for delivering polyions to a cell |
| 10/16/2002 | EP1248830A1 Antimicrobial compositions |
| 10/16/2002 | EP1248790A1 Proton pump inhibitors |
| 10/16/2002 | EP1248774A2 Polyhydroxystilbenes and stilbene oxides as antipsoriatic agents and protein kinase inhibitors |
| 10/16/2002 | EP1248652A2 Stable aqueous deoxyfructosazine solution |
| 10/16/2002 | EP1248650A2 Improved dna vaccines for production-type animals |
| 10/16/2002 | EP1248644A1 Method for enhancing the presentation of exogenous antigen by human antigen-presenting cells and opsonized micro particle complexes for applying this |
| 10/16/2002 | EP1248636A1 Dextrin containing compositions for prevention of adhesions |
| 10/16/2002 | EP1248630A1 Composition, in particular cosmetic or dermatological composition, containing oligosaccharides and preparation method and cosmetic treatment method |
| 10/16/2002 | EP1248619A1 Amorphous paroxetine compositon |
| 10/16/2002 | EP1248613A1 Clonidine preparations |
| 10/16/2002 | EP1248600A1 Improved pharmaceutical formulations |
| 10/16/2002 | EP1248599A1 Multi-particulate form of medicament, comprising at least two differently coated forms of pellet |
| 10/16/2002 | EP1248597A1 Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate |
| 10/16/2002 | EP1248596A2 Implantation kit comprising a support phase and a solvent |
| 10/16/2002 | EP1173521B1 Stable, aqueous dispersions and stable, water-dispersible dry powders of xanthophylls, and production and use of the same |
| 10/16/2002 | EP1098660B1 Encapsulation of water soluble peptides |
| 10/16/2002 | EP1083884B1 Process for the stabilisation of polyvinylpyrrolidone formulations |
| 10/16/2002 | EP1030566B1 Use of liquid carbohydrate fermentation product in foods |
| 10/16/2002 | EP1019417B1 Phospholipid analogue compounds |
| 10/16/2002 | EP0998279B1 Pharmaceutical injection solution containing taxol |
| 10/16/2002 | EP0949927B1 Pharmaceutical composition containing osteogenesis-promoting substance and a polyethylene glycol |
| 10/16/2002 | EP0877605B1 Solid instant-release forms of administration and process for producing the same |
| 10/16/2002 | EP0831826B1 Pharmaceutical composition comprising a proteinase inhibitor and a monoglyceride |
| 10/16/2002 | EP0789559B2 Pharmaceutical composition containing a fusible carrier and method for producing the same |
| 10/16/2002 | EP0759303B1 Colon-specific drug release system |
| 10/16/2002 | EP0749277B1 Coprocessed galactomannan - glucomannan |
| 10/16/2002 | EP0721343B1 Pharmaceutical formulations of nerve growth factor |
| 10/16/2002 | EP0619742B1 Transfection of lung via aerosolized transgene delivery |
| 10/16/2002 | EP0528978B1 Mikrocaspules for controlled release and their use to stimulate nerve fiber growth |
| 10/16/2002 | CN1375004A Methods and compsotions for inhibiting the function of polynucleotide sequences |
| 10/16/2002 | CN1374969A FAP-activated anti-tumor compounds |
| 10/16/2002 | CN1374875A Heterobifunctional poly(ethylene Glycol) derivatives and methods for their preparation |
| 10/16/2002 | CN1374874A Use of fatty acid/amino acid soaps to enhance antimicrobial effectiveness of topical pharmaceutical compositions |
| 10/16/2002 | CN1374873A Anionic amino acid based surfactants to enhance antimicrobial effectiveness of topical pharmaceutical compositions |
| 10/16/2002 | CN1374872A Stabilization of macrolides |
| 10/16/2002 | CN1374867A Quetiapine granules |
| 10/16/2002 | CN1374862A Directly compressible, ultra fine acetaminophen compositions and process for producing same |
| 10/16/2002 | CN1374859A 药物粉剂 Drug powder |
| 10/16/2002 | CN1374858A For mulations for parenteral use of estramustine phosphate with improved pharmacological properties |
| 10/16/2002 | CN1374857A Formulations for parenteral use of estramustine phosphate and sulfoalkyl ether cyclodextrins |
| 10/16/2002 | CN1374838A Method for stabilizing liquid nutritional products and products so stabilized |
| 10/16/2002 | CN1374835A Method for the production of polyvinylpyrrolidone-iodine in an aqueous solution |
| 10/16/2002 | CN1374132A Prepn of core-shell type nano compound hydroxyapatiti-liposome particle |
| 10/16/2002 | CN1374035A Process for producing one or more kinds of dry powder of carotenoid |
| 10/15/2002 | US6465626 Pharmaceutical compositions of chitosan with type-A gelatin |
| 10/15/2002 | US6465525 Latent reactive blood compatible agents |
| 10/15/2002 | US6465522 Anthraquinone anticancer drugs |
| 10/15/2002 | US6465440 Antimutagenic compositions for treatment and prevention of photodamage to skin |
| 10/15/2002 | US6465435 Prevention and/or treatment of antibiotic associated diarrhea or pseudomembranous colitis; binding and eliminating toxins a and b from gastrointestinal tract using oligosaccharide sequence attached to inert support by nonpetidyl linker |
| 10/15/2002 | US6465434 Methods and compositions for the inhibition of cancer metastasis mediated by endothelial adhesion molecules |
| 10/15/2002 | US6465426 Acylation |
| 10/15/2002 | US6465425 Biodegradable materials, such as polymers, encapsulating protein medicaments (such as beta-ifn) can be employed as a sustained delivery system |
| 10/15/2002 | US6465011 Formulations comprising lipid-regulating agents |
| 10/15/2002 | US6465010 Means for creating a mass having structural integrity |
| 10/15/2002 | US6465009 Water soluble polymer-based rapidly dissolving tablets and production processes thereof |
| 10/15/2002 | US6465008 For therapy of tumors |
| 10/15/2002 | US6465005 Steroid as a crystallization inhibitor during storage; inhibitor selected from an estrogen, a progestogen, an androgen and a glucocorticoid |
| 10/15/2002 | US6465003 Drug delivery |
| 10/15/2002 | US6464994 Diaper dermatitis preventative medication and a method for making and using same |
| 10/15/2002 | US6464992 Topical micronutrient delivery system and uses thereof |
| 10/15/2002 | US6464990 Nanoemulsion based on ethylene oxide and propylene oxide block copolymers and its uses in the cosmetics, dermatological and/or ophthalmological fields |
| 10/15/2002 | US6464988 Glipizide-cyclodextrin inclusion complexes and their pharmaceutical composition |
| 10/15/2002 | US6464987 Pharmaceutical compositions capable of being gelled |
| 10/15/2002 | US6464961 Polymeric delivery and release systems for oral care actives |
| 10/15/2002 | US6464959 Protective colloid stabilizer. |
| 10/15/2002 | CA2337750C Therapeutic or cosmetic compositions containing dimeric or polymeric forms of hydroxyacids, and their therapeutic use |
| 10/15/2002 | CA2277801C Preparation of particles for inhalation |
| 10/15/2002 | CA2043253C Cyclodextrin complex |
| 10/12/2002 | CA2362004A1 Fusion proteins |
| 10/12/2002 | CA2342970A1 Fusion proteins |
| 10/10/2002 | WO2002079778A2 In vivo delivery methods and compositions |
| 10/10/2002 | WO2002079417A2 Methods of delivery of exogenous proteins to the cytosol and uses thereof |
| 10/10/2002 | WO2002079415A2 Reducing the immunogenicity of fusion proteins |
| 10/10/2002 | WO2002079394A2 Synthesis and use of glycodendrimer reagents |
| 10/10/2002 | WO2002079393A2 Dynamic action reference tools |
| 10/10/2002 | WO2002079299A1 Agent for the prevention and treatment of sexually transmitted diseases-i |
| 10/10/2002 | WO2002079298A1 Agents for the prevention and treatment of sexually transmitted diseases -ii |
| 10/10/2002 | WO2002079232A2 Reducing the immunogenicity of fusion proteins |
| 10/10/2002 | WO2002078757A1 Skin-compatible hydrogel adhesives |
| 10/10/2002 | WO2002078756A1 Polymerized hydrogel adhesive |
| 10/10/2002 | WO2002078747A2 Pregabalin lactose conjugates |
| 10/10/2002 | WO2002078746A1 Novel chocolate composition as delivery system for nutrients and medications |
| 10/10/2002 | WO2002078730A2 Use of neublastin polypeptides for treating neuropathic pain |
| 10/10/2002 | WO2002078728A2 Peptides for the treatment of wound contracture |